710971

Zydus Pharmaceuticals (USA) Inc — FEI 3008444937

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 22, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Pennington, NJ (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
672821 CFR 314.80(b)Failure to review ADE information